Contract HHSO10033003T

Partner Therapeutics, Inc. · Department Of Health And Human Services · September 29, 2020

Firm Fixed PriceFull & Open CompetitionNAICS 325414IDIQ Task Order

Partner Therapeutics, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 29, 2020 for $37.63 million (current value) of work in biological product (except diagnostic) manufacturing. Performance is in Bridgewater, NJ. This is a task or delivery order issued under parent IDIQ HHSO100201300005I. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 30, 2021. If all options are exercised, the contract could reach $37.63 million.

Current value
$37.63M
Modifications
3
Latest September 30, 2021

Contract details

PIID
HHSO10033003T
Parent IDIQ
HHSO100201300005I
Award type
Delivery Order
Pricing
Firm Fixed Price
Competition
Full And Open Competition
NAICS
325414 · Biological Product (Except Diagnostic) Manufacturing
Product / service
Health R&D Services; Health Care Services; Experimental Development
Place of performance
Bridgewater, NJ
First action
September 29, 2020
Latest action
September 30, 2021

Description

TO PROVIDE SUPPLEMENTAL FUNDING.

Modification timeline

  • September 30, 2021
    Mod P00002 · Funding Only Action
    $37.63M
  • September 13, 2021
    Mod P00002 · Other Administrative Action
    FOR OTHER FUNCTIONS
    $506.4K
  • September 10, 2021
    Mod P00006 · Other Administrative Action
    EVALUATION OF COAGULATION PATHWAY-TARGETING DRUGS IN THE RABBIT MODEL OF ACUTE RADIATION SYNDROME (ARS) FOR POTENTIAL NEW INDICATIONS AS ARS MEDICAL COUNTERMEASURES
    $8.10M
  • September 29, 2020
    Mod P00003 · Other Administrative Action
    TASK ORDER BIO-AMT-1011
    $1.95M

Similar contracts

RecipientAgencyDateObligated
Bio-Rad Laboratories, Inc.Department Of Health And Human ServicesMarch 31, 2026$20.6K
Georgia Tech Research CorpDepartment Of Health And Human ServicesMarch 28, 2026$145.8K
Seqirus IncDepartment Of Health And Human ServicesMarch 25, 2026$23.7K
Seqirus IncDepartment Of Health And Human ServicesMarch 24, 2026$0
Battelle Memorial InstituteDepartment Of Health And Human ServicesMarch 19, 2026$2.80M
Sanofi Vaccines Us Inc.Department Of Health And Human ServicesMarch 19, 2026$53.21M

Top contractors in NAICS 325414

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Advanced Technology International10$225.00M
2Sanofi Vaccines Us Inc.5$27.10M
3Meridian Medical Technologies, Llc2$16.41M
4American National Red Cross, The12$5.59M
5Boehringer Ingelheim Animal Health USA Inc3$3.53M
6Versiti Blood Health, Inc.12$2.52M
7American National Red Cross, The1$1.93M
8Miltenyi Biotec, Inc.3$1.50M
9Artemis Technologies Inc2$983.6K
10Oklahoma Blood Institute3$885.0K

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HHSO10033003T?

Contract HHSO10033003T is a federal contract awarded to Partner Therapeutics, Inc. by Department Of Health And Human Services on September 29, 2020 for $37.63 million of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 3 times since the base award.

Who won contract HHSO10033003T?

Partner Therapeutics, Inc. won contract HHSO10033003T from Department Of Health And Human Services.

How much is contract HHSO10033003T worth?

Contract HHSO10033003T has obligated $0 to date but carries a potential ceiling of $37.63 million if fully funded and all options are exercised.